← All candidates
Four insider buys in the last year — $30.00M in all.
24 filings on record.
QTTBQ32 Bio Inc.
NasdaqCM · Healthcare · $447.44M
$10.86
-2.95% · Sep 18
Four insider buys in the last year — $30.00M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 4 buys● 5 sells◆ 6 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what QTTB ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$447.44M
Float
14.5M
49% public
Short % float
Pro
Price / profit
4.8
Price / future profit
—
Price / sales
8.3
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Xu Diyong
Bought $10.00M on May 28 — 1,250,000 sh @ $8.00, held indirect, 36% of their stake.
No completed positions to measure
10% owner
Orbimed Advisors LLC
Bought $10.00M on May 28 — 1,250,000 sh @ $8.00, held indirect, 36% of their stake.
1 of 2 positions beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
3 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
7 more transactions on Pro →Context
Wall St
$14.25 avg target
+31.2% vs today · 4 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26−$0.54 act+$0.14
Q4 '25$4.58 act+$5.44
Q3 '25−$0.60 act+$0.59
Q2 '25−$0.78 act+$0.20
Coverage
QTTB Stock Hits 18-Month High, Heads Toward Recording Its Best Ever Month – What’s Driving The Investor Optimism?Stocktwits · 05-27Q32 Bio Secures $55 Million Private Placement to Advance Alopecia Areata Pipeline (QTTB)InvestorsHub · 05-27Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a BetZacks · 05-26Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to TradeZacks · 05-08
The file stays open
24 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice